Education and Training
Prevention of Persistent Opioid Use in Mothers
Our previous work has identified the group of women at risk for prolonged pain, opioid use and poor functional recovery after childbirth. The optimal intervention to mitigate this risk is unknown. We propose to test an analgesic adjutant that is commonly used for post-operative pain compared to placebo to improve post-partum recovery.
Stanford is currently not accepting patients for this trial.
Intervention(s):
- drug: Gabapentin
- drug: Placebo
Eligibility
Inclusion Criteria:
- Delivery within 5 days, able to provide informed consent, English speaker
Exclusion Criteria:
- Opiate use disorder
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
Female
Not currently accepting new patients for this trial
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Pamela Flood, MD, MA
201-370-3933
Not Recruiting